Added to YB: 2024-10-29
Pitch date: 2024-10-28
VISTN.OL [bullish]
Vistin Pharma ASA
-18.68%
current return
Author Info
Arthakranti Investing's goal is to exceed the high benchmarks set by my algorithms by uncovering equities that are reasonably priced and have the potential for steady growth over a 1-3 year holding period. Sign up for the newsletter.
Company Info
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide.
Market Cap
NOK 1.0B
Pitch Price
NOK 25.21
Price Target
N/A
Dividend
5.30%
EV/EBITDA
9.93
P/E
16.68
EV/Sales
2.41
Sector
Pharmaceuticals
Category
growth
Metformin's Miracle Maker - Vistin Pharma ASA
VISTN.OL: Metformin API maker, 44% rev growth, 86M NOK EBITDA. Doubled capacity, top 5 globally. Diabetes market growing, new uses emerging. 15% stake in CF Pharma, aiming for multi-product CDMO. Strong insider ownership. Risks: forex, costs, diabetes slowdown, CDMO integration.
Read full article (4 min)